HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts.

Abstract
Polyglutamine (polyQ) disorders are inherited neurodegenerative conditions defined by a common pathogenic CAG repeat expansion leading to a toxic gain-of-function of the mutant protein. Consequences of this toxicity include activation of heat-shock proteins (HSPs), impairment of the ubiquitin-proteasome pathway and transcriptional dysregulation. Several studies in animal models have shown that reducing levels of toxic protein using small RNAs would be an ideal therapeutic approach for such disorders, including spinocerebellar ataxia-7 (SCA7). However, testing such RNA interference (RNAi) effectors in genetically appropriate patient cell lines with a disease-relevant phenotype has yet to be explored. Here, we have used primary adult dermal fibroblasts from SCA7 patients and controls to assess the endogenous allele-specific silencing of ataxin-7 by two distinct siRNAs. We further identified altered expression of two disease-relevant transcripts in SCA7 patient cells: a twofold increase in levels of the HSP DNAJA1 and a twofold decrease in levels of the de-ubiquitinating enzyme, UCHL1. After siRNA treatment, the expression of both genes was restored towards normal levels. To our knowledge, this is the first time that allele-specific silencing of mutant ataxin-7, targeting a common SNP, has been demonstrated in patient cells. These findings highlight the advantage of an allele-specific RNAi-based therapeutic approach, and indicate the value of primary patient-derived cells as useful models for mechanistic studies and for measuring efficacy of RNAi effectors on a patient-to-patient basis in the polyQ diseases.
AuthorsJanine Scholefield, Lauren Watson, Danielle Smith, Jacquie Greenberg, Matthew J A Wood
JournalEuropean journal of human genetics : EJHG (Eur J Hum Genet) Vol. 22 Issue 12 Pg. 1369-75 (Dec 2014) ISSN: 1476-5438 [Electronic] England
PMID24667781 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATXN7 protein, human
  • Ataxin-7
  • DNAJA1 protein, human
  • HSP40 Heat-Shock Proteins
  • Nerve Tissue Proteins
  • RNA, Small Interfering
  • UCHL1 protein, human
  • Ubiquitin Thiolesterase
Topics
  • Alleles
  • Ataxin-7
  • Cell Line
  • Fibroblasts (metabolism)
  • Gene Silencing
  • Genotyping Techniques
  • HSP40 Heat-Shock Proteins (genetics, metabolism)
  • Humans
  • Nerve Tissue Proteins (genetics, metabolism)
  • Neurodegenerative Diseases (genetics, therapy)
  • Phenotype
  • Polymorphism, Single Nucleotide
  • RNA Interference
  • RNA, Small Interfering (genetics, metabolism)
  • Ubiquitin Thiolesterase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: